None of the UGT2B17 SNPs studied were associated with prostate cancer risk, however the UGT2B17 cis -acting SNP, rs17147338, showed borderline significance for increased risk of prostate cancer in an allele dose dependent fashion (OR = 1.65, 95% CI = 1.00, 2.70), after adjusting for age, race and BMI (Table 3 ).
← all excerpts
Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
1
—
—